A world leader in allogeneic adult stem cell manufacturing and research, Stemedica Cell Technologies, Inc. announced the completion of its proprietary master bank of mesenchymal bone marrow-derived stem cells.

Dr. Amescua will be responsible for liaison with regulatory agencies in Latin America regarding approvals of Stemedica's allogeneic adult stem cell products for use in clinical (human) trials which follow the criteria required by the FDA in the Uni

Lev Verkh is now a part of Stemedica, the allogeneic adult stem cells manufacturing company for effective stem cell clinical trials, thus improving the life of humans.